ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

NCAB Accepts Plan for Organ Systems Program, Remains Split On Some Issues

February 11, 1983

Bush Tax Cut, Economic Slowdown Turn Up Heat On Budget Competition.

July 20, 2001

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981